Innovative Biotherapeutics X-BODY Biosciences specializes in discovering novel biotherapeutic compounds using a highly diverse DNA-tagged human antibody library, making it an attractive partner for organizations seeking cutting-edge antibody discovery solutions.
Startup Growth Potential With a small team of 2-10 employees and funding of 2.7 million USD, X-BODY is likely in the early development phase, representing potential for early-stage collaborations or investments in innovative biotechnologies.
Limited Revenue Profile Having a revenue range of zero to one million USD, X-BODY presents an opportunity for sales of research tools, licensing, or developmental partnerships aimed at expanding their therapeutic pipeline.
Industry Alignment Operating within the biotechnology research sector, X-BODY aligns with companies and institutions focused on antibody therapeutics, creating potential for academic partnerships, licensing agreements, or joint ventures.
Competitive Landscape Positioned among small biotech firms with similar R&D focuses, X-BODY offers prospects for strategic collaborations, licensing deals, or technology licensing to enhance its discovery capabilities and accelerate product development.
$10M$25M
$50M$100M
$10M$25M
$100M$250M
$10M$25M
$25M$50M
$10M$25M
$50M$100M
$10M$25M| X-BODY Biosciences Email Formats | Percentage |
| First.Last@x-bodybiosciences.com | 25% |
| FLast@x-bodybiosciences.com | 25% |
| First.Last@x-bodybiosciences.com | 25% |
| FLast@x-bodybiosciences.com | 25% |
Biotechnology ResearchMassachusetts, United States2-10 Employees
X-BODY is a privately held biotechnology company focused on discovering novel biotherapeutic compounds. The company’s mission is to apply its innovative capabilities and remarkably diverse DNA-tagged human antibody library to the discovery of human antibodies against novel therapeutic targets.
Company Overview
Funding & FinancialsX-BODY Biosciences has raised a total of $2.7M of funding over 2 rounds. Their latest funding round was raised on Feb 12, 2013 in the amount of $2.7M.
X-BODY Biosciences's revenue is estimated to be in the range of $1M
Funding & FinancialsX-BODY Biosciences has raised a total of $2.7M of funding over 2 rounds. Their latest funding round was raised on Feb 12, 2013 in the amount of $2.7M.
X-BODY Biosciences's revenue is estimated to be in the range of $1M
1-888-653-2347 
support@leadiq.com